• June 16-19, 2025
  • Boston Convention & Exhibition Center

Sessions

Loading

Targeting the Brain: How Biotech is Uncovering the Biology of Brain Disease for Precision Neurotherapeutics

Tuesday, June 04, 2024
Breakout Session
Brain Health
26A
Brain disorders are perhaps the most important unmet medical need today, yet developing effective new neurotherapeutics continues to challenge the life science industry. Biotechs are bringing innovative technologies to uncover the function and dysfunction of the brain at the molecular and cellular level in health and disease. Session attendees will hear from top leaders in the field of neuroscience as they discuss powerful new tools for identifying and validating targeted therapeutic strategies. Panelists will discuss how innovative approaches, including genomics, machine learning, physics, and RNA-based medicines, are creating programs that promise more personalized precision medicines and better clinical outcomes.
Moderator
Alaa Halawa, MBA
Executive Director and Head of Healthcare, US Ventures
Mubadala Capital
Speakers
Carol Suh, MBA
Co-founder & Chief Operating Officer
Neumora
Joanne Taylor, PhD
Senior Vice President, Research
Gain Therapeutics
Richard Shea, MBA
CEO
Basking Biosciences
Craig Thompson
CEO
Cerevance
Back to Session List

BIO DOUBLE HELIX SPONSORS

Thanks to our sponsors for supporting our mission to drive a revolution to cure patients, protect our climate, and nourish humanity.

Loading

BIO HELIX SPONSORS